BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24587937)

  • 1. Influence of hypertension on neurocognitive domains in nondemented Parkinson's disease patients.
    Jones JD; Jacobson C; Murphy M; Price C; Okun MS; Bowers D
    Parkinsons Dis; 2014; 2014():507529. PubMed ID: 24587937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease.
    Jones JD; Malaty I; Price CC; Okun MS; Bowers D
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1073-8. PubMed ID: 22776043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age.
    Kim JW; Cheon SM; Park MJ; Kim SY; Jo HY
    J Clin Neurol; 2009 Sep; 5(3):133-8. PubMed ID: 19826564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes.
    Mahmood Z; Van Patten R; Nakhla MZ; Twamley EW; Filoteo JV; Schiehser DM
    J Int Neuropsychol Soc; 2020 Oct; 26(9):894-905. PubMed ID: 32375913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Parkinson's Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study.
    Jones JD; Tanner JJ; Okun M; Price CC; Bowers D
    J Int Neuropsychol Soc; 2017 Apr; 23(4):322-331. PubMed ID: 28162137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mild cognitive impairment in early-stage Parkinson's disease.
    Hanna-Pladdy B; Jones K; Cabanban R; Pahwa R; Lyons KE
    Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):168-78. PubMed ID: 23741229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supine hypertension in Parkinson's disease and multiple system atrophy.
    Fanciulli A; Göbel G; Ndayisaba JP; Granata R; Duerr S; Strano S; Colosimo C; Poewe W; Pontieri FE; Wenning GK
    Clin Auton Res; 2016 Apr; 26(2):97-105. PubMed ID: 26801189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
    Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
    Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.
    Zhang JR; Chen J; Yang ZJ; Zhang HJ; Fu YT; Shen Y; He PC; Mao CJ; Liu CF
    Chin Med J (Engl); 2016 Feb; 129(4):379-85. PubMed ID: 26879009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson's disease.
    Zimmermann R; Gschwandtner U; Hatz F; Schindler C; Bousleiman H; Ahmed S; Hardmeier M; Meyer A; Calabrese P; Fuhr P
    Dement Geriatr Cogn Disord; 2015; 39(3-4):207-14. PubMed ID: 25591733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of decision-making and cognitive impairment in Parkinson's disease.
    Pagonabarraga J; García-Sánchez C; Llebaria G; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2007 Jul; 22(10):1430-1435. PubMed ID: 17534944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.
    Sforza M; Assogna F; Rinaldi D; Sette G; Tagliente S; Pontieri FE
    Neurol Sci; 2018 Aug; 39(8):1459-1462. PubMed ID: 29627942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.